Announcements Trials
Browse Landscape

Phase

Phase 1 20Phase 2 17Phase 3 7Phase 1/2 4Phase NA 2Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 35Glioblastoma 10Breast Neoplasms 9Gliosarcoma 8Osteosarcoma 7Melanoma 7Bone Neoplasms 7Stomach Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Lung Neoplasms 6Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma, Alveolar Soft Part 4Colorectal Neoplasms 4Colonic Neoplasms 4Brain Neoplasms 4Rectal Neoplasms 3Oligodendroglioma 3Neoplasms 3Lymphoma 3Liver Neoplasms 3Gastrointestinal Neoplasms 3Desmoplastic Small Round Cell Tumor 3Dendritic Cell Sarcoma, Interdigitating 3Astrocytoma 3Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Sarcoma, Kaposi 2Rhabdomyosarcoma 2

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Acquired Immunodeficiency Syndrome × Sarcoma × Clear all
NCT03316274 2024-06-25

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

University of California, San Francisco

Phase EARLY_PHASE1 Completed
12 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡